These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6132462)

  • 1. [Influence of protein binding on dialysis clearance of several beta-blocking agents in chronically hemodialysed patients].
    Decourt S; Roux A; Baglin A; Aubert P; Prinseau J; Flouvat B
    Therapie; 1982; 37(6):635-40. PubMed ID: 6132462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
    Decourt S; Roux A; Baglin A; Domart M; Aubert P; Flouvat B; Fritel D
    Acquis Med Recent; 1977; ():181-94. PubMed ID: 20725
    [No Abstract]   [Full Text] [Related]  

  • 3. [The protein binding of talinolol].
    Trausch B; Oertel R; Richter K; Gramatté T
    Pharmazie; 1995 Jan; 50(1):72. PubMed ID: 7886130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and clearance of ciprofloxacin and amikacin in continuous hemodialysis].
    Cotera A; Aguila R; Gaete L; Saffie A; Lorca E; Thambo S
    Rev Med Chil; 1995 Jun; 123(6):742-8. PubMed ID: 8525228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
    McDonnell PA; Caldwell GW; Masucci JA
    Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloramphenicol hemodialysis clearance.
    Blouin RA; Erwin WG; Dutro MP; Bustrack JA; Rowse KL
    Ther Drug Monit; 1980; 2(4):351-4. PubMed ID: 7222188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis clearance of buflomedil in hemodialysed patients.
    Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
    Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro enantioselective displacement of propranolol from protein binding sites by acetyl salicylic acid and salicylic acid.
    Rezaei Z; Khabnadideh S; Hemmateenejad B; Dehghani Z
    Int J Pharm; 2007 Sep; 342(1-2):78-81. PubMed ID: 17590545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple, sensitive and specific radioreceptor assay for beta-adrenergic antagonist drugs.
    Innis RB; Bylund DB; Snyder SH
    Life Sci; 1978 Nov; 23(20):2031-7. PubMed ID: 31538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Organic trace element pollution in water--a potential health risk for long-term dialysis patients].
    Knopp D; Unger G; Niessner R
    Zentralbl Hyg Umweltmed; 1994 Jun; 195(5-6):509-15. PubMed ID: 7916879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorcainide kinetics and protein binding in patients with end-stage renal disease.
    Somani P; Simon V; Gupta RK; King P; Shapiro RS; Stockard H
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):121-5. PubMed ID: 6715079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blocking agents].
    Suzuki M
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():978-82. PubMed ID: 8753603
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating beta-adrenoceptor blocking factors in asthma.
    Basran GS; Ball AJ; Hanson JM; Morley J; Turner-Warwick M
    Eur J Respir Dis Suppl; 1984; 135():226-8. PubMed ID: 6145614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis.
    Keller F; Wilms H; Schultze G; Offerman G; Molzahn M
    Clin Nephrol; 1983 Apr; 19(4):201-5. PubMed ID: 6851257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Manganese blood level in chronically hemodialysed patients].
    Versieck J; Barbier F; Hoste J; de Rudder J
    Nouv Presse Med; 1978 Jun; 7(25):2253. PubMed ID: 673793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.